Skip to main content

HIV-1-Specific Cytotoxic T-Cell Assays

  • Protocol
Book cover HIV Protocols

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 17))

Abstract

Cytotoxic T-cells (CTL) provide the basis of protective immunity in many viral infections by appearing early in the immune response and becoming involved with the elimination of virus by lysis of infected cells. A considerable amount of evidence suggests that CTL may be an especially important component of the host defense against HIV-1 (1,2) . Strong CTL activity is seen early during the course of infection (3,4), in nonprogressor individuals, some of whom have been infected for a decade or more with HIV-1 (5,6) and also in some HIV-1 exposed sex workers (7) and babies (8,9) who remain HIV-1-negative.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rowland-Jones, S. and McMichael, A. (1993) Cytotoxic T lymphocytes in HIV infection. Semin. Virol. 4, 83–94.

    Article  CAS  Google Scholar 

  2. Lederman, M. M. (1996) Role of cytotoxic T lymphocytes in the control of HIV-1 infection and HIV-1 disease progression. Cur. Opin. Infect. Dis. 9, 14–18.

    Article  Google Scholar 

  3. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkwosky, W., Farthing, C., and Ho, D. D. (1994) Temporal association of cellular immune responses with the initial viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650–4655.

    PubMed  CAS  Google Scholar 

  4. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M., and Oldstone, M. B. A. (1994) Virus-specific CD8+ cytotoxic T lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68,6103–6110.

    PubMed  CAS  Google Scholar 

  5. Harrer, T., Harrer, E., Kalams, S. A., Elbeik, T., Staprans, S. I., Feinberg, M. B., et al. (1996) Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV Type 1 infection. AIDS Res. Hum. Retrovir. 12, 585–592.

    Article  PubMed  CAS  Google Scholar 

  6. Klein, M. R., van Baalen, C. A., Holwerda, A. M., Kerkhof Garde, S. R., Bende, R. J., Keet, I. P., et al. (1995) Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long term asymptomatics. J. Exp. Med. 181, 1365–1372.

    Article  PubMed  CAS  Google Scholar 

  7. Rowland-Jones, S., Sutton, J., Ariyoshi, K., Dong, T., Gotch, F., McAdam, S., et al. (1995) HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1, 59–64.

    Article  PubMed  Google Scholar 

  8. Cheynier, R., Langlade-Demoyen, P., Marescot, M. R., Blanche, S., Blondin, G., Wain-Hobson, S., et al. (1992) Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1 infected mothers. Eur. J. Immunol. 2, 2211–2217.

    Article  Google Scholar 

  9. Rowland-Jones, S., Nixon, D. F., Aldhous, M. C., Gotch, F., Ariyoshi, K., Hallam, N., et al. (1993) HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341, 860–861.

    Article  PubMed  CAS  Google Scholar 

  10. Walker, B. D., Chakrabarti, S., Moss, B., Paradis, T. J., Flynn, T., Durno, A. G., et al. (1987) HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328, 345–348.

    Article  PubMed  CAS  Google Scholar 

  11. Hoffenbach, A., Langlade-Demoyen, P., Dadaglio, G., Vilmer, E., Michel, F., Mayaud, C, et al. (1989) Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142,452–462.

    PubMed  CAS  Google Scholar 

  12. Koenig, S., Earl, P., Powell, B., Pantaleo, G., Merli, S., Moss, B., et al. (1988) Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus I (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. Proc. Natl. Acad. Sci. USA 85, 8638–8642.

    Article  PubMed  CAS  Google Scholar 

  13. Riviere, Y., Tanneau-Salvadori, F., Regnault, A., Lopez, O., Sansonetti, P., Guy, B., et al. (1989) Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J. Virol. 63, 2270–2277.

    PubMed  CAS  Google Scholar 

  14. Blazevic, V., Ranki, A., and Krohn, K. J. E. (1995) Helper and cytotoxic T cell responses of HIV Type-1 infected individuals to synthetic peptides of REV. AIDS Res. and Hum. Retrovir. 11, 1335–1342.

    Article  CAS  Google Scholar 

  15. Nixon, D. F. and McMichael, A. J. (1991) Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 5, 1049–1059.

    PubMed  CAS  Google Scholar 

  16. Hammond, S. A., Bollinger, R. C., Stanhope, P. E., Quinn, T. C., Schwartz, D., Clements, M. L., and Siliciano, R. F. (1992) Comparative clonal analysis of human immunodeficiency virus type-1 (HIV-l)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J. Exp. Med. 176, 1531–1542.

    Article  PubMed  CAS  Google Scholar 

  17. Curiel, T. J., Wong, J. T., Gorczyca, P. F., Schooley, R. T., Walker, B. D., et al. (1993) CD4+ human immunodeficiency virus type-1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood of an HIV-infected individual. AIDS Res. Hum. Retrovir. 9, 61–68.

    Article  PubMed  CAS  Google Scholar 

  18. Ratto, S., Sitz, K. V., Scherer, A., Loomis, L. D., Cox, J. H., Redfield, R. R., and Birx, D. L. (1996) CD4+ T-lymphocyte lines developed from HIV-1 seropositive patients recognize difference epitopes within the V3 loop. J. AIDS 11, 128–136.

    CAS  Google Scholar 

  19. Earl, P. L. and Moss, B. (1992) Expression of proteins in mammalian cells using vaccinia. Current Protocols In Molecular Biology, vol 2 (Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K., eds.) units 15.1-18.9.

    Google Scholar 

  20. van Baalen, C. A., Klein, M. R., Geretti, A. M., Keet, R. I., Miedema, F., van Els, C. A., and Osterhaus, A. D. (1993) Selective in vitro expansion of HLA Class I-restricted HIV-1 gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor rrequencies. AIDS 7, 781–786.

    Article  PubMed  Google Scholar 

  21. Goteh, F., McAdam, S. N., Allsopp, C. E. M., Gallimore, A., Elvin, J., Kieny, M. P., et al. (1993) Cytotoxic T cells in HTV-2 seropositive Gambians. J. Immunol. 151,3361–3369.

    Google Scholar 

  22. McElrath, M., Siliciano, R. F., and Weinhold, K. J. (1997) HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization and quantitation. AIDS Res. Hum. Retrovir. 13, 211–216.

    Article  PubMed  CAS  Google Scholar 

  23. Ferrari, G., Humphrey, W., McElrath, M.J., Excler, J. L., Duliege, A. M., Clements, M. L., et al. (1997). Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. P.N.A.S. 94, 1396–1401.

    Article  PubMed  CAS  Google Scholar 

  24. Carmichael, A., Alp, N., and Borysiewicz, L. (1992) Quantitating the HIV-1 specific cytotoxic T cell response, in Cytotoxic T Cells in HIV and Other Retroviral Infections (Racz, P., Letvin N. L., and Gluckman, J. C., eds.), S. Karger, Basel, pp. 30–39.

    Google Scholar 

  25. Fazekas de St Groth, S. (1982) The evaluation of limiting dilution analysis. J. Immunol. Methods 49, R11–R23.

    Article  PubMed  CAS  Google Scholar 

  26. Strijbosch, L. W. J., Does, R. J. M. M., and Buurman, W. A. (1988) Computer aided design and evaluation of limiting and serial dilution experiments. Int. J. Biomed. Comput. 23, 279–290.

    Article  PubMed  CAS  Google Scholar 

  27. Geretti, A. M., Dings, M. E., van Els, C. A. van Baalen, C. A., Wijnholds, F. J., Borleffs, J. C., and Osterhaus, A. D. (1996) Human immunodeficiency virus Type 1 (HIV-1)-and Epstein-Barr Virus specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1 infected persons. J. Infect. Dis. 174, 34–45.

    PubMed  CAS  Google Scholar 

  28. Carini, C. and Essex, M. (1994) Interleukin 2-dependent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals. AIDS Res. Hum. Retrovir. 10, 121–130.

    Article  PubMed  CAS  Google Scholar 

  29. Ferrari, G., King, K., Rathbun, K., Place, C. A., Packard, M. V., Bartlett, J. A., et al. (1995) IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp) Clin. Exp. Immunol. 101, 239–248.

    PubMed  CAS  Google Scholar 

  30. Blomberg, K., Granberg, C., Hemmilä, I., and Lövgren, T. (1986) Europium-labeled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence. J. Immunol. Methods 86, 225–233.

    Article  PubMed  CAS  Google Scholar 

  31. Blomberg, K., Hautala, R., Lovgren, J., Mukkala, V. M., Lindqvist, C., and Akerman, K. (1996) Time resolved fluorimetric assay for natural killer activity using target cells labeled with a fluorescence enhancing ligand. J. Immunol. Methods 193, 199–206.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Cox, J.H. (1999). HIV-1-Specific Cytotoxic T-Cell Assays. In: Michael, N.L., Kim, J.H. (eds) HIV Protocols. Methods in Molecular Medicine™, vol 17. Humana Press. https://doi.org/10.1385/0-89603-369-4:355

Download citation

  • DOI: https://doi.org/10.1385/0-89603-369-4:355

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-369-6

  • Online ISBN: 978-1-59259-601-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics